These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 29316044)

  • 1. Global transcriptome profiling of mild relapsing-remitting versus primary progressive multiple sclerosis.
    Koch MW; Ilnytskyy Y; Golubov A; Metz LM; Yong VW; Kovalchuk O
    Eur J Neurol; 2018 Apr; 25(4):651-658. PubMed ID: 29316044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis.
    Ratzer R; Søndergaard HB; Christensen JR; Börnsen L; Borup R; Sørensen PS; Sellebjerg F
    Mult Scler; 2013 Dec; 19(14):1841-8. PubMed ID: 24085340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability.
    Kiselev I; Bashinskaya V; Baulina N; Kozin M; Popova E; Boyko A; Favorova O; Kulakova O
    Mult Scler Relat Disord; 2019 Apr; 29():130-136. PubMed ID: 30711878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global map of physical interactions among differentially expressed genes in multiple sclerosis relapses and remissions.
    Tuller T; Atar S; Ruppin E; Gurevich M; Achiron A
    Hum Mol Genet; 2011 Sep; 20(18):3606-19. PubMed ID: 21676896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of MIR21 in CD4+ T cells from patients with relapsing-remitting multiple sclerosis associates with lower miRNA-21 levels and concomitant up-regulation of its target genes.
    Ruhrmann S; Ewing E; Piket E; Kular L; Cetrulo Lorenzi JC; Fernandes SJ; Morikawa H; Aeinehband S; Sayols-Baixeras S; Aslibekyan S; Absher DM; Arnett DK; Tegner J; Gomez-Cabrero D; Piehl F; Jagodic M
    Mult Scler; 2018 Sep; 24(10):1288-1300. PubMed ID: 28766461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis.
    Booth DR; Arthur AT; Teutsch SM; Bye C; Rubio J; Armati PJ; Pollard JD; Heard RN; Stewart GJ;
    J Mol Med (Berl); 2005 Oct; 83(10):822-30. PubMed ID: 16075257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of primary progressive multiple sclerosis.
    Cree BA
    Handb Clin Neurol; 2014; 122():211-30. PubMed ID: 24507520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis.
    Iwanowski P; Losy J; Kramer L; Wójcicka M; Kaufman E
    J Neurol Sci; 2017 Sep; 380():22-26. PubMed ID: 28870573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of replication of KIF1B gene in an Italian primary progressive multiple sclerosis cohort.
    Martinelli-Boneschi F; Esposito F; Scalabrini D; Fenoglio C; Rodegher ME; Brambilla P; Colombo B; Ghezzi A; Capra R; Collimedaglia L; Coniglio G; De Riz M; Serpente M; Cantoni C; Scarpini E; Martinelli V; Galimberti D; Comi G
    Eur J Neurol; 2010 May; 17(5):740-5. PubMed ID: 20067515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of IFN-β inducible gene expression in primary-progressive and relapsing-remitting multiple sclerosis.
    Boppana S; Mindur JE; Balashov KE; Dhib-Jalbut S; Ito K
    J Neuroimmunol; 2013 Dec; 265(1-2):68-74. PubMed ID: 24200257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole transcriptome analysis of multiple Sclerosis patients reveals active inflammatory profile in relapsing patients and downregulation of neurological repair pathways in secondary progressive cases.
    Nali LH; Olival GS; Sousa FTG; de Oliveira ACS; Montenegro H; da Silva IT; Dias-Neto E; Naya H; Spangenberg L; Penalva-de-Oliveira AC; Romano CM
    Mult Scler Relat Disord; 2020 Sep; 44():102243. PubMed ID: 32559700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis.
    Pulkkinen K; Luomala M; Kuusisto H; Lehtimäki T; Saarela M; Jalonen TO; Elovaara I
    Acta Neurol Scand; 2004 May; 109(5):342-7. PubMed ID: 15080861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of interleukin-4 receptor alpha chain variants in multiple sclerosis.
    Hackstein H; Bitsch A; Bohnert A; Hofmann H; Weber F; Ohly A; Linington C; Mäurer M; Poser S; Rieckmann P; Bein G
    J Neuroimmunol; 2001 Feb; 113(2):240-8. PubMed ID: 11164908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for association of chromosome 10 open reading frame (C10orf27) gene polymorphisms and multiple sclerosis.
    Goertsches R; Baranzini SE; Morcillo C; Nos C; Camiña M; Oksenberg JR; Montalban X; Comabella M
    Mult Scler; 2008 Apr; 14(3):412-4. PubMed ID: 18208870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DNA Methylation Profile of CD14+ Monocytes Changes in Primary Progressive Multiple Sclerosis].
    Kiselev IS; Kulakova OG; Baturina OA; Kabilov MR; Boyko AN; Favorova OO
    Mol Biol (Mosk); 2023; 57(5):819-826. PubMed ID: 37752647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating dendritic cells of multiple sclerosis patients are proinflammatory and their frequency is correlated with MS-associated genetic risk factors.
    Thewissen K; Nuyts AH; Deckx N; Van Wijmeersch B; Nagels G; D'hooghe M; Willekens B; Cras P; Eijnde BO; Goossens H; Van Tendeloo VF; Stinissen P; Berneman ZN; Hellings N; Cools N
    Mult Scler; 2014 Apr; 20(5):548-57. PubMed ID: 24057429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
    Honardoost MA; Kiani-Esfahani A; Ghaedi K; Etemadifar M; Salehi M
    Gene; 2014 Jul; 544(2):128-33. PubMed ID: 24792898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain.
    Ramil E; Sánchez AJ; González-Pérez P; Rodríguez-Antigüedad A; Gómez-Lozano N; Ortiz P; Arroyo R; De las Heras V; Vilches C; García-Merino A
    Mult Scler; 2010 Feb; 16(2):139-46. PubMed ID: 20007426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression in familial and nonfamilial MS.
    Koch M; Uyttenboogaart M; Heerings M; Heersema D; Mostert J; De Keyser J
    Mult Scler; 2008 Apr; 14(3):300-6. PubMed ID: 18208881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-572 expression in multiple sclerosis patients with different patterns of clinical progression.
    Mancuso R; Hernis A; Agostini S; Rovaris M; Caputo D; Clerici M
    J Transl Med; 2015 May; 13():148. PubMed ID: 25947625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.